ロード中...
2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy
OBJECTIVES/SPECIFIC AIMS: Peripheral neuropathy is the dose limiting toxicity of paclitaxel treatment. Paclitaxel pharmacokinetics (PK), specifically the Cmax and amount of time the concentration remains above 0.05 µM (Tc>0.05), have been associated with occurrence of severe, clinician-documented...
保存先:
| 出版年: | J Clin Transl Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cambridge University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6798474/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/cts.2017.114 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|